Nixon Peabody Trust’s ASML ASML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.3M Buy
11,736
+140
+1% +$243K 1.38% 16
2026
Q2
$23.1M Sell
11,596
-177
-2% -$282K 1.63% 15
2026
Q1
$15.6M Sell
11,773
-1,001
-8% -$1.37M 1.24% 21
2025
Q4
$13.7M Sell
12,774
-3,515
-22% -$3.67M 1.03% 29
2025
Q3
$15.8M Buy
16,289
+224
+1% +$176K 1.15% 23
2025
Q2
$12.9M Buy
16,065
+198
+1% +$142K 1% 32
2025
Q1
$10.5M Buy
15,867
+5,610
+55% +$4.08M 0.89% 40
2024
Q4
$7.11M Buy
+10,257
New +$7.37M 0.59% 48

Other funds holding ASML

Nixon Peabody Trust's ASML Position: Q3 2026 in Review

Nixon Peabody Trust increased its ASML (ASML) stake by 1.2% in Q3 2026, buying an estimated $243K and bringing the position to 11,736 shares worth $21.3M. The position accounts for 1.38% of the portfolio, ranked #16.

Nixon Peabody Trust first reported a position in ASML in Q4 2024 and has held it in 8 quarters since. The position peaked at $23.1M in Q2 2026. 2,135 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Nixon Peabody Trust held 11,736 shares of ASML worth $21.3M as of Q3 2026.
  • Nixon Peabody Trust bought 140 ASML shares in Q3 2026, an estimated $243K.
  • ASML made up 1.38% of Nixon Peabody Trust's portfolio in Q3 2026, its #16 holding.
  • Nixon Peabody Trust first reported a position in ASML in Q4 2024 and has held it in 8 quarters since.
  • Nixon Peabody Trust's ASML position peaked at $23.1M in Q2 2026.
  • 2,135 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Nixon Peabody Trust's 13F filing for Q3 2026, filed 23 Oct 2026.